Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-30
2007-10-30
Richter, Johann (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
10974670
ABSTRACT:
The present invention provides an improved process for the preparation of the anti-migraine drug, (R)-5-(2-benzenesulphonylethyl)-3-N-methylpyrrolidin-2-ylmethyl)-1H-indole (eletriptan), available commercially as the hydrobromide salt, and an intermediate and dimer-free products obtained from such process.
REFERENCES:
patent: 5545644 (1996-08-01), Macor et al.
patent: 5607951 (1997-03-01), Macor et al.
patent: 6110940 (2000-08-01), Harding et al.
patent: 0 592 438 (1997-08-01), None
patent: WO 1992/06973 (1992-04-01), None
Kojima, wt al., “Fluorescent Properties of Model Chromophores of Tyrosine-66 Substituted Mutants of Aequorea Green Fluorescent Protein”, Tetrahedron Letters, 1998, pp. 5239-5242, vol. 39, No. 29.
Willems, et al., “Porcine Carotid Vascular Effects of Eletriptan (UK-0116,044): A New 5-HT1b/1D Receptor Agonist with Anti-Migraine Activity”, Naunyn-Scmiedeberg's Arch Pharmacology, 1998, pp. 212-219, vol. 358, No. 2.
Pfizer Inc.
Polster, II Philip B.
Richter Johann
Sackey Ebenezer
LandOfFree
Process for the preparation of eletriptan does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of eletriptan, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of eletriptan will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3877866